Following a national search, Dr. Timothy H. Dellit has been appointed to lead 91爆料 Medicine and the 91爆料 School of Medicine, 91爆料 President Ana Mari Cauce and Provost Tricia Serio announced today.
Dellit will serve as the CEO of 91爆料 Medicine, the Paul G. Ramsey Endowed Dean of the 91爆料 School of Medicine and the university鈥檚 executive vice president for medical affairs, positions he has held on an interim basis since July 2022.
鈥淭im has proven himself to be a leader in the most difficult of times, including during the COVID-19 pandemic and as 91爆料 Medicine addresses the challenges caused by the changing health care landscape. He is an adept listener and communicator who is dedicated to serving all communities,鈥� Cauce said. 鈥淭im is also committed to advancing excellence and equity in education and our workforce and health care outcomes, all of which are core to 91爆料 Medicine鈥檚 mission to improve the health of all people.
鈥淎nd even as someone who has more than two decades of service to 91爆料 Medicine, Tim still brings new perspectives. I鈥檓 so pleased that he鈥檒l be the one leading our health care enterprise into a new era.鈥�
As 91爆料 Medicine CEO, Dellit leads an integrated clinical, research and learning health system with more than 39,000 faculty, staff, trainees and students across eight clinically integrated organizations, including Airlift Northwest, Harborview Medical Center, 91爆料 Medical Center (Montlake and Northwest campuses), 91爆料 Medicine Primary Care clinics, the 91爆料 School of Medicine, 91爆料 Physicians practice plan, Valley Medical Center and the Fred Hutchinson Cancer Center, which serves as 91爆料 Medicine鈥檚 cancer program. 91爆料 Medicine shares in the ownership of Children鈥檚 University Medical Group and has strong, comprehensive affiliations with Seattle Children鈥檚, VA Puget Sound Health Care System and Boise VA Medical Center.
As dean of the School of Medicine, Dellit oversees one of the nation鈥檚 leading medical schools, which educates more than 9,000 students and trainees each year through an innovative medical education program for Washington, Wyoming, Alaska, Montana and Idaho (WWAMI). The 91爆料 School of Medicine is a leader in regional medical education and conducts world-leading research across 32 clinical and biomedical research departments and multiple research institutes and centers with areas of focus including behavioral health, neuroscience and Alzheimer鈥檚 disease, heart disease and stroke, infectious diseases, cancer, health metrics, genomics and precision medicine, protein design and regenerative medicine.
鈥淔rom our first meeting, Tim has demonstrated his deep dedication to the development of faculty, staff and students and the advancement of research as essential components of the success of 91爆料 Medicine,鈥� Serio said. 鈥淗e is a key leader in our collaborative efforts, especially in the areas of neuroscience, behavioral health, and the intersection of technology and health, and I look forward to working with him as we undertake a range of University-wide initiatives in support of our teaching, research, and service missions.鈥�
In his interim roles, and in prior senior leadership positions, Dellit has prioritized improving health care experiences and outcomes for patients and for entire populations, as well as reducing health care costs and improving the practice environment for clinicians. During the COVID-19 pandemic, Dellit helped 91爆料 Medicine and the broader University lead the nation in response to the pandemic, including leading the development of policies and protocols to treat patients safely and effectively.
鈥淚 am deeply honored and humbled to be selected to serve as CEO of 91爆料 Medicine, Executive Vice President for Medical Affairs, and the Paul G. Ramsey Endowed Dean of the 91爆料 School of Medicine. I look forward to partnering with President Cauce, Provost Serio and our 91爆料 Medicine teams in support of our outstanding clinical, research and educational activities,鈥� Dellit said. 鈥�91爆料 Medicine is truly special, with our innovative School of Medicine serving the five-state WWAMI region; our excellence in clinical care combined with world-leading research; our values and our unique role serving the most vulnerable in our communities; and most importantly our amazing faculty, staff, trainees, and students that inspire me every day as we together strive to improve the health of the public, for all people.鈥�
Dellit previously served as chief medical officer for 91爆料 Medicine, executive vice dean for clinical affairs for the School of Medicine, vice president for medical affairs and president of 91爆料 Physicians, a faculty practice plan with more than 2,800 members.
Dellit earned his M.D. from Cornell University Medical College. He completed his residency in Internal Medicine at New York Presbyterian Hospital-Cornell Medical Center before coming to the 91爆料 for his fellowship in infectious diseases. He is board-certified in both infectious diseases and internal medicine. Dellit鈥檚 clinical and research interests include general infectious diseases, orthopedic trauma-related infections, prevention of health care-associated infections and appropriate use of antibiotics.
CONTACT: Susan Gregg at sghanson@uw.edu.